"beta-Galactosidase" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, 
	MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, 
	which enables searching at various levels of specificity.
	
	
		
			
			
				A group of enzymes that catalyzes the hydrolysis of terminal, non-reducing beta-D-galactose residues in beta-galactosides. Deficiency of beta-Galactosidase A1 may cause GANGLIOSIDOSIS, GM1.
    
			
			
				
				
					
						| Descriptor ID | D001616 | 
					
						| MeSH Number(s) | D08.811.277.450.410.100 | 
					
						| Concept/Terms | beta-Galactosidasebeta-Galactosidasebeta Galactosidasebeta-Galactosidasesbeta Galactosidaseslac Z ProteinProtein, lac ZLactasesbeta-D-Galactosidasebeta D Galactosidase
 | 
					
				
			 
			
				Below are MeSH descriptors whose meaning is more general than "beta-Galactosidase".
				
			 
			
			
				Below are MeSH descriptors whose meaning is more specific than "beta-Galactosidase".
				
			 
		 
	 
 
                                        
                                            
	
	
		
			
			
					
				This graph shows the total number of publications written about "beta-Galactosidase" by people in this website by year, and whether "beta-Galactosidase" was a major or minor topic of these publications. 
				
					 
                    To see the data from this visualization as text, 
click here. 
                
		            | Year | Major Topic | Minor Topic | Total | 
|---|
| 1995 | 0 | 2 | 2 | 
| 1996 | 0 | 1 | 1 | 
| 1997 | 1 | 9 | 10 | 
| 1998 | 0 | 2 | 2 | 
| 1999 | 0 | 3 | 3 | 
| 2000 | 0 | 1 | 1 | 
| 2001 | 0 | 1 | 1 | 
| 2002 | 0 | 2 | 2 | 
| 2003 | 0 | 1 | 1 | 
| 2004 | 0 | 2 | 2 | 
| 2005 | 1 | 2 | 3 | 
| 2006 | 0 | 6 | 6 | 
| 2007 | 0 | 4 | 4 | 
| 2008 | 0 | 3 | 3 | 
| 2009 | 0 | 1 | 1 | 
| 2010 | 2 | 3 | 5 | 
| 2011 | 0 | 1 | 1 | 
| 2013 | 0 | 2 | 2 | 
| 2014 | 0 | 2 | 2 | 
| 2015 | 1 | 1 | 2 | 
| 2016 | 0 | 1 | 1 | 
| 2017 | 0 | 1 | 1 | 
| 2018 | 0 | 1 | 1 | 
| 2019 | 0 | 1 | 1 | 
                    To return to the timeline, 
click here.
                 
			 	
			
			
			
			
				Below are the most recent publications written about "beta-Galactosidase" by people in Profiles.
						
					
								- 
								Kynurenine inhibits autophagy and promotes senescence in aged bone marrow mesenchymal stem cells through the aryl hydrocarbon receptor pathway. Exp Gerontol. 2020 02; 130:110805. 
- 
								Kallistatin attenuates endothelial senescence by modulating Let-7g-mediated miR-34a-SIRT1-eNOS pathway. J Cell Mol Med. 2018 09; 22(9):4387-4398. 
- 
								Kallistatin reduces vascular senescence and aging by regulating microRNA-34a-SIRT1 pathway. Aging Cell. 2017 08; 16(4):837-846. 
- 
								Transgenic expression of cyclooxygenase-2 (COX2) causes premature aging phenotypes in mice. Aging (Albany NY). 2016 10 07; 8(10):2392-2406. 
- 
								Multifunctional nanoparticles for gene delivery and spinal cord injury. J Biomed Mater Res A. 2015 11; 103(11):3474-82. 
- 
								Optical imaging of targeted ?-galactosidase in brain tumors to detect EGFR levels. Bioconjug Chem. 2015 Apr 15; 26(4):660-8. 
- 
								Fibroblasts that resist cigarette smoke-induced senescence acquire profibrotic phenotypes. Am J Physiol Lung Cell Mol Physiol. 2014 Sep 01; 307(5):L364-73. 
- 
								Generation of mice carrying a knockout-first and conditional-ready allele of transforming growth factor beta2 gene. Genesis. 2014 Sep; 52(9):817-26. 
- 
								Resveratrol enhances ionizing radiation-induced premature senescence in lung cancer cells. Int J Oncol. 2013 Dec; 43(6):1999-2006. 
- 
								Tissue-specific effects of saposin A and saposin B on glycosphingolipid degradation in mutant mice. Hum Mol Genet. 2013 Jun 15; 22(12):2435-50.